|
30824.01.02
|
ANORO INH.PD.DOS (55+22)mcg/DOSE BTx 1 inhaler ELLIPTA (30 doses)
|
|
30,37 |
34,91 |
48,10 |
GlaxoSmithKline Ireland Ltd
|
|
28210.01.03
|
AVAMYS NASPR.SUS 27,5MC/ΨΕΚΑΣΜΟ 1 Φιάλη σε πλαστική συσκευή x 120 ψεκασμούς
|
|
4,35 |
5,00 |
6,89 |
GlaxoSmithKline Ireland Ltd
|
|
29978.03.02
|
BENLYSTA INJ.SOL 200MG/1ML BTx4 PF.PENS x1ML
|
|
686,01 |
762,98 |
861,32 |
GlaxoSmithKline Ireland Ltd
|
|
29978.01.01
|
BENLYSTA PD.C.SO.IN 120MG/VIAL BTx1VIAL
|
|
116,32 |
133,70 |
164,40 |
GlaxoSmithKline Ireland Ltd
|
|
29978.02.01
|
BENLYSTA PD.C.SO.IN 400MG/VIAL BTx1VIAL
|
|
387,82 |
431,33 |
498,36 |
GlaxoSmithKline Ireland Ltd
|
|
32534.01.01
|
BLENREP PD.C.SO.IN 100MG BTx 1 VIAL
|
|
5.643,78 |
6.277,05 |
6.786,75 |
GlaxoSmithKline Ireland Ltd
|
|
30782.01.02
|
INCRUSE INH.PD.DOS 55mcg/DOSE-UMECLIDINIUM (που ισοδυναμούν με UMECLIDIUNIUM BROMIDE 65mcg/DOSE) BTx1 συσκευή εισπνοών (Ellipta) x 30 δόσεις
|
|
18,19 |
20,91 |
28,81 |
GlaxoSmithKline Ireland Ltd
|
|
23258.01.01
|
INTEGRILIN INJ.SO.INF 0.75MG/ML VIALX100ML
|
|
32,07 |
36,86 |
50,80 |
GlaxoSmithKline Ireland Ltd
|
|
23258.02.01
|
INTEGRILIN INJ.SOL 2MG/ML VIALX10ML
|
|
10,19 |
11,71 |
16,13 |
GlaxoSmithKline Ireland Ltd
|
|
32722.01.01
|
JEMPERLI C/S.SOL.IN 500MG/VIAL 1 VIAL
|
|
4.649,02 |
5.170,67 |
5.590,52 |
GlaxoSmithKline Ireland Ltd
|
|
30823.01.02
|
LAVENTAIR INH.PD.DOS (55+22)mcg/DOSE BTx 1 inhaler ELLIPTA (30 doses)
|
|
30,37 |
34,91 |
48,10 |
GlaxoSmithKline Ireland Ltd
|
|
30654.02.02
|
RELVAR ELLIPTA INH.PD.DOS (184+22)mcg/DOSE BTx1 συσκευή εισπνοών x30 δόσεις
|
|
23,48 |
26,99 |
37,20 |
GlaxoSmithKline Ireland Ltd
|
|
30654.01.02
|
RELVAR ELLIPTA INH.PD.DOS (92+22)mcg/DOSE BTx1 συσκευή εισπνοών x30 δόσεις
|
|
21,15 |
24,32 |
33,52 |
GlaxoSmithKline Ireland Ltd
|
|
30786.02.02
|
REVINTY ELLIPTA INH.PD.DOS (184+22)mcg/DOSE 1 συσκευή εισπνοών x30 δόσεις
|
|
23,48 |
26,99 |
37,20 |
GlaxoSmithKline Ireland Ltd
|
|
30786.01.02
|
REVINTY ELLIPTA INH.PD.DOS (92+22)mcg/DOSE 1 συσκευή εισπνοών x30 δόσεις
|
|
21,15 |
24,32 |
33,52 |
GlaxoSmithKline Ireland Ltd
|
|
28363.02.02
|
VOLIBRIS F.C.TAB 10MG/TAB BT x 30 σε BLIST (PVC/PVDC/ALU)
|
|
1.217,59 |
1.354,21 |
1.496,47 |
GlaxoSmithKline Ireland Ltd
|
|
28363.01.02
|
VOLIBRIS F.C.TAB 5MG/TAB BT x 30 σε BLIST (PVC/PVDC/ALU)
|
|
1.144,69 |
1.273,13 |
1.406,87 |
GlaxoSmithKline Ireland Ltd
|
|
24222.01.01
|
ZEFFIX F.C.TAB 100MG/TAB BTX28(BLISTERS)
|
|
17,32 |
19,91 |
27,43 |
GlaxoSmithKline Ireland Ltd
|
|
24222.02.01
|
ZEFFIX ORAL.SOL 5MG/ML FLX240ML
|
|
8,48 |
9,75 |
13,44 |
GlaxoSmithKline Ireland Ltd
|
|
32228.01.02
|
ZEJULA CAPS 100MG/CAP 56 x1 καψάκιο (μιας δόσης) σε κυψέλη (PCTFE/PVC/AL)
|
|
3.300,49 |
3.670,83 |
3.968,91 |
GlaxoSmithKline Ireland Ltd
|
|
32228.02.03
|
ZEJULA F.C.TAB 100MG/TAB 56 ΔΙΣΚΙΑ ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC/AL/VINYL/ACRYLIC/PAPER)
|
|
2.918,78 |
3.246,28 |
3.509,88 |
GlaxoSmithKline Ireland Ltd
|
|
32228.02.01
|
ZEJULA F.C.TAB 100MG/TAB 56 Χ 1 ΔΙΣΚΙΑ (ΜΙΑΣ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC/AL/VINYL/ACRYLIC)
|
|
2.918,78 |
3.246,28 |
3.509,88 |
GlaxoSmithKline Ireland Ltd
|
